文献速递儿童青少年精神

去甲肾上腺素转运体甲基化与ADHD中NET表达及多动冲动症状的关联:一项PET研究

Association of norepinephrine transporter methylation with in vivo NET expression and hyperactivity-impulsivity symptoms in ADHD measured with PET.
PubMed 文献 · Mol Psychiatry · 2019-08-05

该研究比较了23例成人ADHD患者与23名健康对照的去甲肾上腺素转运体(NET)启动子DNA甲基化水平,其中18对完成了(S,S)-[18F]FMeNER-D2 PET显像。结果发现患者NET启动子特定区域存在高甲基化,且该区域甲基化与丘脑、蓝斑和中缝核的NET分布及多动冲动症状严重程度呈负相关。

要点

  • 成人ADHD患者NET启动子区域1存在高甲基化。
  • 区域1甲基化与丘脑、蓝斑、中缝核NET分布负相关。
  • 区域1多位点甲基化与多动冲动症状严重程度负相关。

核心结论

  • ADHD患者存在NET启动子DNA甲基化改变,且与脑内NET表达及多动冲动症状相关。

研究设计与样本

  • 研究纳入23例成人ADHD患者和23名健康对照测定NET启动子DNA甲基化。
  • 其中18例患者和18名对照接受(S,S)-[18F]FMeNER-D2 PET显像定量多个脑区NET。

主要发现

  • 多个CpG位点NET甲基化水平在组间存在显著差异。
  • NET启动子区域1在患者中较对照呈高甲基化。
  • 患者中该区域某CpG位点甲基化与丘脑、蓝斑和中缝核NET分布呈负相关。
  • 区域1多个位点甲基化与多动冲动症状严重程度呈负相关。

临床怎么用

  • NET启动子甲基化可能作为ADHD表观遗传调控的候选标志物。
  • 区域1甲基化水平与脑内NET分布及多动冲动症状相关,提示其临床关联性。

局限性

  • 样本量较小(23例患者和23名对照,PET亚组各18例)。
  • 研究为横断面设计,无法推断因果。
  • 原文未报告甲基化与PET测量的具体数值及统计细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder with a robust genetic influence. The norepinephrine transporter (NET) is of particular interest as it is one of the main targets in treatment of the disorder. As ADHD is a complex and polygenetic condition, the possible regulation by epigenetic processes has received increased attention. We sought to determine possible differences in NET promoter DNA methylation between patients with ADHD and healthy controls. DNA methylation levels in the promoter region of the NET were determined in 23 adult patients with ADHD and 23 healthy controls. A subgroup of 18 patients with ADHD and 18 healthy controls underwent positron emission tomography (PET) with the radioligand (S,S)-[18F]FMeNER-D2 to quantify the NET in several brain areas in vivo. Analyses revealed significant differences in NET methylation levels at several cytosine-phosphate-guanine (CpG) sites between groups. A defined segment of the NET promoter ("region 1") was hypermethylated in patients in comparison with controls. In ADHD patients, a negative correlation between methylation of a CpG site in this region and NET distribution in the thalamus, locus coeruleus, and the raphe nuclei was detected. Furthermore, methylation of several sites in region 1 was negatively associated with the severity of hyperactivity-impulsivity symptoms. Our results point to an epigenetic dysregulation in ADHD, possibly due to a compensatory mechanisms or additional factors involved in transcriptional processing.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Sigurdardottir HL, Kranz GS, Rami-Mark C, et al. Association of norepinephrine transporter methylation with in vivo NET expression and hyperactivity-impulsivity symptoms in ADHD measured with PET. Mol Psychiatry. 2019. PMID: 31383926. doi:10.1038/s41380-019-0461-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。